Back to Atlas
BSemi-durableStandard research/education caution
CMP-0233
Research
RAGE antagonist peptide (RAP)
Anti-inflammatory / Glycation
May reduce AGE/RAGE inflammatory signaling in experimental models
Reading this compound Reference only
Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.
Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.
Mechanism & Use
- Compound type
- Peptide
- Primary mechanism
- Blocks RAGE-ligand interactions such as S100P/HMGB1/RAGE signaling
- Primary market use
- Inflammation / glycation research
Pharmacology
- Molecular weight (Da)
- 1,272.56
- Oral bioavailability
- N/A (peptide; not oral)
- Half-life
- ~5–60 min parent peptide; analogs may be longer
- Route tags
- SubQ; Injectable; route-dependent
- Evidence level
- Preclinical
- Clinical status
- Research
- Value-for-money score
- 3 / 10
Reported protocol signal
No clean popular protocol found in uploaded sources; create as research/reference entry and verify before public protocol display.
For orientation only. See disclaimer — always consult a licensed clinician before use.
Notes
Bioavailability and durability are poor unless delivered locally or modified